Overview
Clemens Mellink practices in Amsterdam, Netherlands. Mr. Mellink is rated as an Advanced expert by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), and Leukemia.
His clinical research consists of co-authoring 19 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 16 articles in the study of Chronic B-Cell Leukemia (CBCL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic B-Cell Leukemia (CBCL)Mr. Mellink isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Mr. Mellink isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Small Lymphocytic Lymphoma (SLL)Mr. Mellink isAdvanced. Learn about Small Lymphocytic Lymphoma (SLL).
- Experienced
- LeukemiaMr. Mellink isExperienced. Learn about Leukemia.
- Teratoma of the MediastinumMr. Mellink isExperienced. Learn about Teratoma of the Mediastinum.